Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danzhu Fuyuan Granule for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy
NCT04498962Unknown
- Start
- Aug 2020
- Primary completion
- Jun 2021
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Open-label trial of Danzhufuyuan Prescription in angina pectoris, vascular dementia and idiopathic membranous nephropathy (IMN) (4 arms). Primary endpoints: Time to ST depression on submaximal exercise Modified Bruce Protocol at 8 weeks, Score on Syndrome Questionnaire of Intermingled Phlegm and Blood Stasis with Chronic Stable Angina at 8 weeks and 4 more. Status: unknown.
02
Drugs
Danzhufuyuan Prescription
03
Conditions
angina pectorisvascular dementiaidiopathic membranous nephropathy (IMN)
Beyond the preview
Go deeper on NCT04498962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04498962.